000 01306 a2200373 4500
005 20250512035336.0
264 0 _c19880728
008 198807s 0 0 eng d
022 _a0262-0898
024 7 _a10.1007/BF01760576
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aZöller, M
245 0 0 _aIFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.
_h[electronic resource]
260 _bClinical & experimental metastasis
_c
300 _a411-29 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aCell Line
650 0 4 _aCell Survival
650 0 4 _aH-2 Antigens
_ximmunology
650 0 4 _aImmunity, Innate
650 0 4 _aImmunization
650 0 4 _aInterferon-gamma
_xpharmacology
650 0 4 _aLung Neoplasms
_xsecondary
650 0 4 _aLymphocyte Activation
_xdrug effects
650 0 4 _aMale
650 0 4 _aMelanoma
_ximmunology
650 0 4 _aMice
650 0 4 _aNeoplasm Metastasis
_ximmunology
650 0 4 _aT-Lymphocytes
_xdrug effects
650 0 4 _aTumor Cells, Cultured
_xdrug effects
773 0 _tClinical & experimental metastasis
_gvol. 6
_gno. 5
_gp. 411-29
856 4 0 _uhttps://doi.org/10.1007/BF01760576
_zAvailable from publisher's website
999 _c3138153
_d3138153